文献
J-GLOBAL ID:202202287857472384
整理番号:22A0479781
抗ウイルス薬Umifenovirの有効性,安全性および忍容性に関する第III相無作為化二重盲検プラセボ対照試験,非重症COVID-19患者における治療の標準的治療【JST・京大機械翻訳】
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients
著者 (21件):
Ramachandran Ravishankar
(CSIR-Central Drug Research Institute, Lucknow)
,
Bhosale Vivek
(CSIR-Central Drug Research Institute, Lucknow)
,
Reddy Himanshu
(King George’s Medical University, Lucknow)
,
Atam Virendra
(King George’s Medical University, Lucknow)
,
Faridi MMA
(ERA’s Lucknow Medical College and Hospital)
,
Fatima Jalees
(ERA’s Lucknow Medical College and Hospital)
,
Shukla Vaibhav
(ERA’s Lucknow Medical College and Hospital)
,
Khan Zaw A
(ERA’s Lucknow Medical College and Hospital)
,
Khan Hana
(ERA’s Lucknow Medical College and Hospital)
,
Singh Vikram
(Ram Manohar Lohia Institute of Medical Sciences, Lucknow)
,
Negi Mahendra Pal Singh
(CSIR-Central Drug Research Institute, Lucknow)
,
Srivastava Mukesh
(CSIR-Central Drug Research Institute, Lucknow)
,
Srivastava Ajay Kumar
(CSIR-Central Drug Research Institute, Lucknow)
,
Tripathi Chandra Bhushan
(CSIR-Central Drug Research Institute, Lucknow)
,
Ghosh Nayan
(CSIR-Central Drug Research Institute, Lucknow)
,
Majumdar Nilanjana
(CSIR-Central Drug Research Institute, Lucknow)
,
Tripathi Raj Kamal
(CSIR-Central Drug Research Institute, Lucknow)
,
Rath Srikanta Kumar
(CSIR-Central Drug Research Institute, Lucknow)
,
Mishra Prabhat Ranjan
(CSIR-Central Drug Research Institute, Lucknow)
,
Sharma Sharad
(CSIR-Central Drug Research Institute, Lucknow)
,
Kundu Tapas K
(CSIR-Central Drug Research Institute, Lucknow)
資料名:
International Journal of Infectious Diseases
(International Journal of Infectious Diseases)
巻:
115
ページ:
62-69
発行年:
2022年
JST資料番号:
W3271A
ISSN:
1201-9712
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)